Seasonal Influenza Vaccination Associated with Reduced Antibiotic Use

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-11-01 20:00 GMT   |   Update On 2023-11-02 07:49 GMT

Seasonal influenza vaccination has emerged as a powerful tool in the fight against antimicrobial resistance (AMR), potentially curbing the need for antibiotics to treat acute respiratory infections. A recent study published in the Journal of Antimicrobial Chemotherapy found the association between influenza vaccination and antimicrobial use, revealing its potential to reduce...

Login or Register to read the full article

Seasonal influenza vaccination has emerged as a powerful tool in the fight against antimicrobial resistance (AMR), potentially curbing the need for antibiotics to treat acute respiratory infections. A recent study published in the Journal of Antimicrobial Chemotherapy found the association between influenza vaccination and antimicrobial use, revealing its potential to reduce unnecessary antibiotic prescriptions.

The study, part of the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) project, focused on patients aged 65 years or older who sought medical attention for upper respiratory infections in Tokyo's 23 wards. 

Through meticulous analysis employing the average treatment effect (ATE) and propensity score matching, the researchers made some significant findings. The data encompassed 244,642 individuals, with 101,734 in both the unvaccinated and vaccinated groups.

The study found that the ATE of vaccination was a negative value for the frequency of antibiotic prescriptions, indicating a significant reduction in unnecessary antibiotic use among the vaccinated group. Specifically, the ATE was -0.004 with a 95% confidence interval of -0.006 to -0.002. This suggests that influenza vaccination can help reduce the need for antibiotics in the treatment of upper respiratory infections.

Furthermore, the study indicated that vaccination was associated with lower rates of healthcare facility consultations. The ATE for this parameter was -0.005, with a 95% confidence interval of -0.007 to -0.004. This reduction in consultations also reflects the vaccine's role in mitigating the burden of upper respiratory infections.

The results of this research have important implications for public health. By reducing unnecessary antibiotic prescriptions and healthcare facility visits for upper respiratory infections, seasonal influenza vaccination not only benefits individual health but also contributes to the global effort to combat antimicrobial resistance.

As the world grapples with the growing challenge of AMR, these findings provide valuable insights into the role that routine vaccination against influenza can play in preserving the effectiveness of antibiotics. In an era where antimicrobial resistance poses a significant threat to human health, vaccination strategies like this may prove crucial in managing the appropriate use of antibiotics.

Source:

Tsuzuki, S., Murata, F., Maeda, M., Asai, Y., Koizumi, R., Ohmagari, N., & Fukuda, H. (2023). Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study. In Journal of Antimicrobial Chemotherapy. Oxford University Press (OUP). https://doi.org/10.1093/jac/dkad340

Tags:    
Article Source : Journal of Antimicrobial Chemotherapy

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News